Company intelligence / Profile preview

Oncologic

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

OncoLogic was a specialized contract research organization (CRO) that focused exclusively on providing clinical development services for oncology-related therapeutics. Founded by industry veterans with deep expertise in cancer research, the company offered comprehensive clinical trial management, including study design, site selection, and regulatory support. OncoLogic was recognized for its high-touch service model and its ability to navigate the complexities of early-phase oncology trials. In 2011, the company was acquired by Aptiv Solutions to strengthen its global oncology capabilities, and Aptiv was subsequently acquired by ICON plc in 2014.

Therapeutic areas: Oncology
Industry: Contract Research Organization

Beyond the preview

Go deeper on Oncologic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncologic.

Explore the full profile